Navigation Links
Animas' Development of a First-Generation Closed Loop Insulin Delivery System Progresses With Data Presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
Date:2/28/2013

WEST CHESTER, Pa., Feb. 28, 2013 /PRNewswire/ -- Animas Corporation announced today positive results from the second phase of human clinical trials of a first-generation, closed-loop insulin delivery system in development, designed to predict a rise or fall in blood glucose and correspondingly increase, decrease, suspend and resume insulin delivery. The data were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference in Paris, France.

The feasibility study of the predictive Hypoglycemia-Hyperglycemia Minimizer (HHM) System* in development was conducted in 20 adults with Type 1 diabetes and designed to investigate the System's ability to adjust insulin dosing to proactively mitigate hypoglycemia and hyperglycemia. The study, which was the first conducted in humans to investigate the configuration of the predictive algorithm, revealed differences in the algorithm's insulin-dosing characteristics and provided insights into the sensitivity of the System. The results also indicated that the System reduced insulin delivery in advance of hypoglycemia and triggered timely warnings. The study was conducted by Animas Corporation in partnership with leading academic research institutions, including the University of California, Santa Barbara; Sansum Diabetes Research Institute; and the Center for Diabetes Technology at the University of Virginia.

"We are encouraged by these results, which strengthen our understanding of the complex algorithms required of a closed-loop insulin delivery system and further our confidence in this technology platform," said Ramakrishna Venugopalan , Director, Research & Development at Animas Corporation.  "The scope of this study also reflects our commitment to create innovative and robust solutions for people living with diabetes."

Animas began collaborating with industry, academia and advocacy organi
'/>"/>

SOURCE Animas Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BiOptix to highlight new carbonic anhydrase data at IBCs Biopharmaceutical Development & Production Week
2. ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications
3. Glide Pharma Completes £14.0 Million ($21.4 Million) Fundraising for Scale Up of Drug and Device Manufacturing Processes and Product Development
4. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
5. Successful Inspection by the FDA of ENCO Pharmaceutical Developments Cary, NC Facility
6. Australian Government Invests in Detection and Management of Blinding Eye Disease and Diabetes Through Intelligent High Resolution Retinal Camera Development by Vision CRC
7. HKTU Announces Development of a New Male Enhancement Supplement
8. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
9. Xenon Announces Appointment of EVP, Research & Development
10. Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project
11. Varian Medical Systems Supports Program to Tap Brain Power of Research and Development Community in Russia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The clinical and ... be the difference between a product,s success or failure. ... and stratify KOL targets – and then to coordinate ... of strong relationships upon which successful KOL engagement rests. ... companies have identified internal inconsistencies in their KOL management ...
(Date:8/29/2014)... The Competitive Intelligence (CI) function is evolving ... leaders who adjust will succeed, and those who don,t ... Practices, LLC study CI leaders from 32 biopharmaceutical organizations ... - Use secondary research whenever possible - it,s effective, ... Internal staff who are creative thinkers provide the CI ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products ... for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it has ... address a potential issue with a clip used ... Axilla application of the SAM Junctional Tourniquet (SJT).  ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2
... peers in examining the rise of adaptive study approaches ... ... 23 Cytel,s renowned adaptive,trial design and implementation experts Cyrus Mehta ... and case,study reviews at the Annual Meeting of the Drug Information ...
... Inc. (Nasdaq: ALXA ) announced today that ... trial of Staccato(R) loxapine (AZ-104) for,the treatment of ... of,the American Headache Society, which being held at ... oral platform abstract presentation,"Inhaled Loxapine, a Dopamine Antagonist, ...
Cached Medicine Technology:Cytel's Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting 2Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting 2
(Date:8/29/2014)... Healthpointe Medical Group, one of ... center from LAXMed. The medical center is less than 2 ... west of the 405 freeway. , The LAX clinic ... LAX center is located at: 8610 S. Sepulveda Blvd., Suite ... Healthpointe LAX office will provide the same comprehensive services ...
(Date:8/29/2014)... The family of a California woman ... dialysis treatments has filed a GranuFlo lawsuit ( http://www.thegranuflolawsuit.com ... of Fresenius Medical Care’s GranuFlo and NaturaLyte dialysis concentrates, ... file d in Alameda County Superior Court on July ... resulted in metabolic alkalosis, a dangerous elevation of ...
(Date:8/29/2014)... 29, 2014 Today, NBC’s “The ... who profiled a handful of safe, back to ... Research. This year, many schools will include earphones ... innovator of hearing wellness solutions, offers the best ... Earphones, offered in yellow, pink and black, sound ...
(Date:8/29/2014)... Reinberg HealthDay Reporter ... majority of American babies are getting the vaccines they ... officials said Thursday. More than 90 percent of ... and rubella (MMR); polio; hepatitis B and chickenpox (varicella), ... Prevention. "Nationally, vaccination among children 19 to 35 ...
(Date:8/29/2014)... Food and Drug Administration (FDA)-approved treatment for decreasing ... effective at reducing fracture risk as other current ... loss. With the use of wide- and small-angle ... out experiments at the U.S. Department of Energy,s ... Laboratory that revealed an additional mechanism underlying raloxifene ...
Breaking Medicine News(10 mins):Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Revealing a novel mode of action for an osteoporosis drug 2
... with a drug that targets two genes that ... this deadly disease, according to cancer researchers. The ... safer and more effective way of targeting cancer-causing ... , "It is a very selective and ...
... message boards, videos and advice , , MONDAY, Sept. 15 ... cancer patients learn more about how they can preserve ... Northwestern University in Chicago. , "It,s overwhelming for ... fertility preservation at the same time that they are ...
... Sept. 15 Yearbook photos capture school,portraits for years ... a,yearbook photo that they would prefer to erase -- ... yearbook photos this year, and to,kick-off the launch of ... & CLEAR(R) is inviting teens to,"Erase Their Worst Year ...
... Consumer coalition calls for quality standards to protect Pennsylvania ... families from inadequate regulations, ... allow facilities to rent rooms to residents that,do not meet ... wheelchairs or walkers., While new assisted living construction would ...
... LSU Health Sciences Center New Orleans School of ... the Robert Wood Johnson Foundation (RWJF) to provide ... disadvantaged backgrounds in an accelerated nursing degree program. ... Career Alternative RN Education, or CARE, Program, expanding ...
... HILL Nearly every child who receives an antipsychotic ... atypical drugs, such as olanzapine and risperidone. However, there ... effective than the older, first-generation medications., ,Now a study ... School of Medicine suggests that molindone, a first-generation drug, ...
Cached Medicine News:Health News:Nanomedical approach targets multiple cancer genes, shrinks tumors more effectively 2Health News:Nanomedical approach targets multiple cancer genes, shrinks tumors more effectively 3Health News:Web Site Helps Cancer Patients With Fertility Preservation 2Health News:CLEAN & CLEAR(R) Is Inviting Teens to 'Erase Their Worst Yearbook Picture' With The NEW CLEAN & CLEAR(R) Advantage(R) Blackhead Eraser(TM) Exfoliating Cleanser 2Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 2Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 3Health News:LSUHSC awarded grant to address nursing shortage 2Health News:First generation antipsychotic drugs as effective as newer ones in some children 2Health News:First generation antipsychotic drugs as effective as newer ones in some children 3
... The Integrity ADx pacemaker ... world's smallest dual-chamber pacemaker, ... pacemaker technology, including the ... the first U.S. commercially ...
... The Affinity pacemaker ... today's smallest, truly automatic ... effective combination of advanced ... Affinity DR pacemaker incorporates ...
Innovative new tools for more efficient patient management begin when the pacemaker is implanted. These sophisticated tools are in effect each day, and they help automate follow-up tasks....
... The first-ever completely automatic ... that make it sophisticated yet ... a wide range of diagnostic ... without clinician intervention. This allows ...
Medicine Products: